From: Tumorigenic and tumoricidal properties of exosomes in cancers; a forward look
 | Biomarker | Source | Molecular level effect | Phenotypic effect | Reference |
---|---|---|---|---|---|
miR | miR-519a-3p | Gastric Cancer | MAPK/ERK pathway | Angiogenesis & Metastasis | [98] |
miR-934 | Colorectal Cancer | PTEN/ PI3K/AKT | Metastasis | [99] | |
miR-146a | Breast Cancer | Wnt/βCatenin | Invasion & Metastasis | [100] | |
miR-128-3p | Colorectal Cancer | TGF-β/SMAD & Jak/STAT3 | EMT | [101] | |
miR-3473b | lung cancer | NF-κB | colonization | [102] | |
miR-345-5p | Colorectal related CAFs | CDKN1A | tumor cell progression & metastasis | [103] | |
miR-20a-5p | CAFs | Wnt/β-catenin | promotes hepatocellular carcinoma | [104] | |
miR-221-3p | M2-MQ | SOCS3/JAK2/STAT3 | osteosarcoma metastasis | [105] | |
miR193a-5p | TAM | TIMP2 | renal cancer progression | [106] | |
miR-3157-3p | non-small cell lung cancer | TIMP/KLF2 | angiogenesis | [107] | |
lncRNA | SNHG16 | breast cancer | TGFβ/SMAD | induction of CD73 + γδ1 Tregs | [108] |
SNHG10 | colorectal cancer | INHBC & TGFβ | inhibit cytotoxicity in NKCs | [109] | |
SNHG1 | Hypoxic breast cancer | Jak2 | proliferation & angiogenesis | [110] | |
PARTI | Esophageal cancer | miR302a-3p/CDC25A | angiogenesis | [111] | |
CDKN2B-AS1 | thyroid cancer | miR-122-5p/ P4HA1 | Migration & Invasion | [112] | |
TTN-AS1 | gastric cancer | miR-499a-5p/ZEB1/CDX2 | growth & metastasis | [113] | |
AP000439.2 | clear cell renal cell carcinoma | STAT3 | tumor progression | [114] | |
PCAT1 | Colorectal Cancer | miR-329-3p/Netrin-1-CD146 | Metastasis | [115] | |
LINC00313 | non-small cell lung cancer | miR-135a-3p/STAT6 | M2-MQ differentiation | [116] | |
NEAT1 | Hepatoblastoma | miR-132/MMP9 | induce BMSCs to myofibroblasts | [117] | |
circRNA | circ_FMN2 | Colorectal cancer | miR-338-3p/MSI1 | Cancer progression | [118] |
circPACRGL | Colorectal cancer | miR-142-3p/miR-506 3p-TGF-β1 | Cancer progression | [119] | |
circCCAR1 | Hepatocellular carcinoma | miR-127-5p/WTAP | dysfunction of CD8 + T cells | [120] | |
circRNA100338 | Hepatocellular Carcinoma | - | Promote metastasis | [121] | |
circTGFBR2 | Hepatocellular Carcinoma | miR-205-5p/ATG5 | Cancer progression | [122] | |
circDennd1b | Pituitary Adenoma | miR-145 5p/ONECUT2 | Cancer progression | [123] | |
circ_0051799 | Lung adenocarcinoma | miR-214-3p/IGF2BP3 /JAK/STAT | Cancer proliferation and metastasis | [124] | |
circ_0005615 | Colorectal cancer | miR-873-5p/FOSL2 | Cancer progression | [125] | |
hsa_circIFNGR2 | Ovarian cancer | miR-378/ST5 | Metastasis | [126] | |
Protein | DNAJB11 | Pancreatic ductal adenocarcinoma | EGFR/MAPK | Cancer development | [127] |
B7-H3 (CD276) | Colorectal cancer | AKT1/mTOR/VEGFA | Angiogenesis & Metastasis | [128] | |
DPP4 | Colon Cancer | Twist1/Smad | Angiogenesis | [129] | |
ENO1 | Hepatocellular Carcinoma | FAK/Src-p38MAPK & integrin α6β4 | Cancer growth and metastasis | [130] | |
CD44 | Gastric Cancer | YAP/CPT1A | Metastasis | [131] | |
GDF15 | Colorectal cancer | Bcl-2/caspase-3 | Muscle atrophy | [132] | |
ITGB1 | Rectal cancer | NFκB | Activation of lung fibroblasts | [133] | |
MLF1 | Intrahepatic cholangiocarcinoa | EGFR/AKT & Wnt/β-catenin | tumor cells’ proliferation and metastasis | [134] | |
MUC13 | Esophageal cancer | GLANT14, MUC3A, MUC1, MUC12, and MUC4/ O-glycan process | Cancer development | [135] | |
RNF126 | Nasopharyngeal carcinoma | PTEN/PI3K/AKT | Cancer growth and metastasis | [136] |